Exactech Brings Personalized Surgery Capability In-House

Joint specialist Exactech, Inc., is to acquire French technology company BlueOrtho SAS in a move that will bring so-called personalized surgery in house.

Background

Exactech has partnered with BlueOrtho since 2009 to develop ExactechGPS® Guided Personalized Surgery system, which was introduced by Exactech in 2010 and fully commercialized in 2014. ExactechGPS currently supports Exactech’s comprehensive knee systems with plans to expand its application to other segments of the company’s portfolio. The system represents an advanced surgical technology that provides orthopaedic surgeons real-time visual guidance and alignment data in total joint arthroplasty. It features a touch screen and proprietary camera system within the sterile field, the only of its kind on the market. 

Exactech will now acquire BlueOrtho for up to 10 million Euros, with 2 million Euros paid at the closing on January 15, 2015 and a potential earn-out amount of up to 8 million Euros based on the achievement of surgical case milestones using the technology.

Company comments

for Exactech

According to Exactech Vice President of Engineering and Development for Large Joints Xavier Sarabia, “This acquisition is a logical next step in our partnership with BlueOrtho. Exactech is strategically invested in this technology because we believe it will become the new standard of patient care in total joint arthroplasty. BlueOrtho is a very talented, highly motivated group of professionals who work well with our staff. By welcoming them officially to the Exactech team, we broaden our engineering competencies to benefit our planned future developments.”

for BlueOrtho

President and CEO Anthony Boyer stated, “The goal of the partnership between BlueOrtho and Exactech has been to develop a significant advancement in technology that improves patient outcomes. Exactech has been an ideal partner, due to their expertise in mechanical instrument design and their understanding of clinical issues related to patient outcomes. We are enthusiastic to build upon this success under the new structure.”

Source: PR Newswire

Share your thoughts

Your email address will not be published. Required fields are marked *